KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Interest Coverage Ratio: 2011-2025

Historic Interest Coverage Ratio for Travere Therapeutics (TVTX) over the last 3 years, with Sep 2025 value amounting to 8.90.

  • Travere Therapeutics' Interest Coverage Ratio rose 144.40% to 8.90 in Q3 2025 from the same period last year, while for Sep 2025 it was -8.03, marking a year-over-year increase of 74.78%. This contributed to the annual value of -28.91 for FY2024, which is 15.57% up from last year.
  • As of Q3 2025, Travere Therapeutics' Interest Coverage Ratio stood at 8.90, which was up 300.32% from -4.44 recorded in Q2 2025.
  • In the past 5 years, Travere Therapeutics' Interest Coverage Ratio registered a high of 8.90 during Q3 2025, and its lowest value of -49.73 during Q1 2024.
  • Its 3-year average for Interest Coverage Ratio is -22.85, with a median of -22.94 in 2024.
  • Data for Travere Therapeutics' Interest Coverage Ratio shows a peak YoY surged of 144.40% (in 2025) over the last 5 years.
  • Travere Therapeutics' Interest Coverage Ratio (Quarterly) stood at -33.40 in 2023, then spiked by 35.06% to -21.69 in 2024, then spiked by 144.40% to 8.90 in 2025.
  • Its Interest Coverage Ratio stands at 8.90 for Q3 2025, versus -4.44 for Q2 2025 and -14.72 for Q1 2025.